276 related articles for article (PubMed ID: 24789780)
1. Mechanistic differences between nucleic acid chaperone activities of the Gag proteins of Rous sarcoma virus and human immunodeficiency virus type 1 are attributed to the MA domain.
Rye-McCurdy TD; Nadaraia-Hoke S; Gudleski-O'Regan N; Flanagan JM; Parent LJ; Musier-Forsyth K
J Virol; 2014 Jul; 88(14):7852-61. PubMed ID: 24789780
[TBL] [Abstract][Full Text] [Related]
2. Matrix domain modulates HIV-1 Gag's nucleic acid chaperone activity via inositol phosphate binding.
Jones CP; Datta SA; Rein A; Rouzina I; Musier-Forsyth K
J Virol; 2011 Feb; 85(4):1594-603. PubMed ID: 21123373
[TBL] [Abstract][Full Text] [Related]
3. The matrix domain contributes to the nucleic acid chaperone activity of HIV-2 Gag.
Pachulska-Wieczorek K; Błaszczyk L; Biesiada M; Adamiak RW; Purzycka KJ
Retrovirology; 2016 Mar; 13():18. PubMed ID: 26987314
[TBL] [Abstract][Full Text] [Related]
4. The human immunodeficiency virus type 1 Gag polyprotein has nucleic acid chaperone activity: possible role in dimerization of genomic RNA and placement of tRNA on the primer binding site.
Feng YX; Campbell S; Harvin D; Ehresmann B; Ehresmann C; Rein A
J Virol; 1999 May; 73(5):4251-6. PubMed ID: 10196321
[TBL] [Abstract][Full Text] [Related]
5. Effect of Mg(2+) and Na(+) on the nucleic acid chaperone activity of HIV-1 nucleocapsid protein: implications for reverse transcription.
Vo MN; Barany G; Rouzina I; Musier-Forsyth K
J Mol Biol; 2009 Feb; 386(3):773-88. PubMed ID: 19154740
[TBL] [Abstract][Full Text] [Related]
6. Retrovirus-specific differences in matrix and nucleocapsid protein-nucleic acid interactions: implications for genomic RNA packaging.
Sun M; Grigsby IF; Gorelick RJ; Mansky LM; Musier-Forsyth K
J Virol; 2014 Jan; 88(2):1271-80. PubMed ID: 24227839
[TBL] [Abstract][Full Text] [Related]
7. The contribution of the primer activation signal to differences between Gag- and NCp7-facilitated tRNA(Lys3) annealing in HIV-1.
Saadatmand J; Niu M; Kleiman L; Guo F
Virology; 2009 Sep; 391(2):334-41. PubMed ID: 19616817
[TBL] [Abstract][Full Text] [Related]
8. In virio SHAPE analysis of tRNA(Lys3) annealing to HIV-1 genomic RNA in wild type and protease-deficient virus.
Seif E; Niu M; Kleiman L
Retrovirology; 2015 May; 12():40. PubMed ID: 25981241
[TBL] [Abstract][Full Text] [Related]
9. Effect of multimerization on membrane association of Rous sarcoma virus and HIV-1 matrix domain proteins.
Dick RA; Kamynina E; Vogt VM
J Virol; 2013 Dec; 87(24):13598-608. PubMed ID: 24109216
[TBL] [Abstract][Full Text] [Related]
10. Molecular mimicry of human tRNALys anti-codon domain by HIV-1 RNA genome facilitates tRNA primer annealing.
Jones CP; Saadatmand J; Kleiman L; Musier-Forsyth K
RNA; 2013 Feb; 19(2):219-29. PubMed ID: 23264568
[TBL] [Abstract][Full Text] [Related]
11. Mechanistic differences between HIV-1 and SIV nucleocapsid proteins and cross-species HIV-1 genomic RNA recognition.
Post K; Olson ED; Naufer MN; Gorelick RJ; Rouzina I; Williams MC; Musier-Forsyth K; Levin JG
Retrovirology; 2016 Dec; 13(1):89. PubMed ID: 28034301
[TBL] [Abstract][Full Text] [Related]
12. Nucleocapsid and matrix protein contributions to selective human immunodeficiency virus type 1 genomic RNA packaging.
Poon DT; Li G; Aldovini A
J Virol; 1998 Mar; 72(3):1983-93. PubMed ID: 9499052
[TBL] [Abstract][Full Text] [Related]
13. Human immunodeficiency virus Type 1 nucleocapsid protein (NCp7) directs specific initiation of minus-strand DNA synthesis primed by human tRNA(Lys3) in vitro: studies of viral RNA molecules mutated in regions that flank the primer binding site.
Li X; Quan Y; Arts EJ; Li Z; Preston BD; de Rocquigny H; Roques BP; Darlix JL; Kleiman L; Parniak MA; Wainberg MA
J Virol; 1996 Aug; 70(8):4996-5004. PubMed ID: 8764006
[TBL] [Abstract][Full Text] [Related]
14. Aspects of HIV-1 assembly that promote primer tRNA(Lys3) annealing to viral RNA.
Saadatmand J; Kleiman L
Virus Res; 2012 Nov; 169(2):340-8. PubMed ID: 22698876
[TBL] [Abstract][Full Text] [Related]
15. Nucleic acid chaperone activity of retroviral Gag proteins.
Rein A
RNA Biol; 2010; 7(6):700-5. PubMed ID: 21045546
[TBL] [Abstract][Full Text] [Related]
16. Hydrodynamic and Membrane Binding Properties of Purified Rous Sarcoma Virus Gag Protein.
Dick RA; Datta SA; Nanda H; Fang X; Wen Y; Barros M; Wang YX; Rein A; Vogt VM
J Virol; 2015 Oct; 89(20):10371-82. PubMed ID: 26246573
[TBL] [Abstract][Full Text] [Related]
17. Nucleic acid binding and chaperone properties of HIV-1 Gag and nucleocapsid proteins.
Cruceanu M; Urbaneja MA; Hixson CV; Johnson DG; Datta SA; Fivash MJ; Stephen AG; Fisher RJ; Gorelick RJ; Casas-Finet JR; Rein A; Rouzina I; Williams MC
Nucleic Acids Res; 2006; 34(2):593-605. PubMed ID: 16449201
[TBL] [Abstract][Full Text] [Related]
18. NC-mediated nucleolar localization of retroviral gag proteins.
Lochmann TL; Bann DV; Ryan EP; Beyer AR; Mao A; Cochrane A; Parent LJ
Virus Res; 2013 Feb; 171(2):304-18. PubMed ID: 23036987
[TBL] [Abstract][Full Text] [Related]
19. Selection of fully processed HIV-1 nucleocapsid protein is required for optimal nucleic acid chaperone activity in reverse transcription.
Wu T; Gorelick RJ; Levin JG
Virus Res; 2014 Nov; 193():52-64. PubMed ID: 24954787
[TBL] [Abstract][Full Text] [Related]
20. TNPO3-Mediated Nuclear Entry of the Rous Sarcoma Virus Gag Protein Is Independent of the Cargo-Binding Domain.
Rice BL; Stake MS; Parent LJ
J Virol; 2020 Aug; 94(17):. PubMed ID: 32581109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
